# Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups

> **NCT00711295** · PHASE3 · COMPLETED · sponsor: **Alachua Government Services, Inc.** · enrollment: 3583 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** H5N1 Influenza Vaccine Whole virion, Vero cell-derived, Inactivated Influenza Vaccine, non-adjuvanted
- **BIOLOGICAL:** H5N1 Influenza Vaccine Whole virion, Vero cell-derived, Inactivated Influenza Vaccine, non-adjuvanted

## Key facts

- **NCT ID:** NCT00711295
- **Lead sponsor:** Alachua Government Services, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-07
- **Final completion:** 2010-10
- **Target enrollment:** 3583 (ACTUAL)
- **Last updated:** 2015-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00711295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00711295, "Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00711295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*